Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Lilly’s Zepbound Cut Risk of Diabetes by 94% in Obese People | Bloomberg Businessweek
Posted
August 21, 2024
Views
268
Likes
2
Comments
1
Engagement
August 21, 2024
268
2
1
1.12%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
8:20Now PlayingWatch Carol and Tim LIVE every day on YouTube().
Bloomberg News Health Care Reporter Madison Muller discusses that patients taking Eli Lilly’s blockbuster weight-loss shot were 94% less likely to develop diabetes in a three-year study that illuminates the long-term health benefits of treating obesity.
Hosts: Tim Stenovec and Katie Greifeld. Producer: Paul Brennan.
See omnystudio.com/listener () for privacy information.
Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.
Subscribe to Bloomberg Podcasts
Listen to more of Bloomberg Businessweek
#Bloomberg #Podcast #News #Businessweek
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
